SignatureFD’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,895
| Closed | -$41.9K | – | 3556 |
|
|
2026
Q1 | $41.9K | Hold |
2,895
| – | – | ﹤0.01% | 1826 |
|
|
2025
Q4 | $41.2K | Buy |
2,895
+714
| +33% | +$7.01K | ﹤0.01% | 1764 |
|
|
2025
Q3 | $17.2K | Buy |
2,181
+513
| +31% | +$3.65K | ﹤0.01% | 2180 |
|
|
2025
Q2 | $9.56K | Buy |
+1,668
| New | +$10.8K | ﹤0.01% | 2367 |
|
|
2025
Q1 | – | Sell |
-661
| Closed | -$6.23K | – | 3358 |
|
|
2024
Q4 | $6.23K | Buy |
661
+425
| +180% | +$4.42K | ﹤0.01% | 2523 |
|
|
2024
Q3 | $2.52K | Hold |
236
| – | – | ﹤0.01% | 2779 |
|
|
2024
Q2 | $2.34K | Buy |
236
+102
| +76% | +$1.05K | ﹤0.01% | 2721 |
|
|
2024
Q1 | $1.58K | Sell |
134
-92
| -41% | -$1.18K | ﹤0.01% | 2866 |
|
|
2023
Q4 | $3.21K | Sell |
226
-759
| -77% | -$8.62K | ﹤0.01% | 2641 |
|
|
2023
Q3 | $12K | Sell |
985
-242
| -20% | -$3.12K | ﹤0.01% | 2105 |
|
|
2023
Q2 | $15.4K | Buy |
1,227
+1,004
| +450% | +$11.9K | ﹤0.01% | 2021 |
|
|
2023
Q1 | $2.47K | Buy |
223
+77
| +53% | +$949 | ﹤0.01% | 2741 |
|
|
2022
Q4 | $1.78K | Buy |
146
+65
| +80% | +$732 | ﹤0.01% | 2845 |
|
|
2022
Q3 | $1K | Hold |
81
| – | – | ﹤0.01% | 2960 |
|
|
2022
Q2 | $1K | Buy |
+81
| New | +$667 | ﹤0.01% | 2909 |
|
|
2022
Q1 | – | Sell |
-82
| Closed | -$1K | – | 3190 |
|
|
2021
Q4 | $1K | Hold |
82
| – | – | ﹤0.01% | 2913 |
|
|
2021
Q3 | $1K | Sell |
82
-151
| -65% | -$1.54K | ﹤0.01% | 2818 |
|
|
2021
Q2 | $2K | Hold |
233
| – | – | ﹤0.01% | 2573 |
|
|
2021
Q1 | $2K | Sell |
233
-36
| -13% | -$557 | ﹤0.01% | 2466 |
|
|
2020
Q4 | $6K | Hold |
269
| – | – | ﹤0.01% | 1889 |
|
|
2020
Q3 | $4K | Buy |
269
+36
| +15% | +$525 | ﹤0.01% | 1965 |
|
|
2020
Q2 | $4K | Hold |
233
| – | – | ﹤0.01% | 1878 |
|
|
2020
Q1 | $2K | Buy |
233
+82
| +54% | +$779 | ﹤0.01% | 1935 |
|
|
2019
Q4 | $1K | Buy |
+151
| New | +$1.38K | ﹤0.01% | 2021 |
|
Other funds holding FOLD
SignatureFD's FOLD Position: Q2 2026 in Review
SignatureFD sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,895 shares — an estimated $41.9K sold.
SignatureFD first reported a position in FOLD in Q4 2019 and held it in 24 quarters. The position peaked at $41.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- SignatureFD reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- SignatureFD sold 2,895 Amicus Therapeutics shares in Q2 2026, an estimated $41.9K.
- SignatureFD first reported a position in Amicus Therapeutics in Q4 2019 and held it in 24 quarters.
- SignatureFD's Amicus Therapeutics position peaked at $41.9K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.